Please assess the completion status of the following clinical trial:

Trial Title: An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects chronically infected with HCV Genotype 1~* HCV RNA viral load of ≥ 10\*5\* IU/mL (100,000 IU/mL) at screening~Exclusion Criteria:~* Subjects with evidence of liver cirrhosis~* Evidence of HCC~* Co-infection with hepatitis B virus, HIV

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- BMS-790052 + BMS-650032 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).